These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2755122)

  • 1. Glucan enhances survival in an intraabdominal infection model.
    Bowers GJ; Patchen ML; MacVittie TJ; Hirsch EF; Fink MP
    J Surg Res; 1989 Aug; 47(2):183-8. PubMed ID: 2755122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria.
    Tzianabos AO; Cisneros RL
    Ann N Y Acad Sci; 1996 Oct; 797():285-7. PubMed ID: 8993382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glucan--a host resistance activator--and ampicillin on experimental intraabdominal sepsis.
    Lahnborg G; Hedström KG; Nord CE
    J Reticuloendothel Soc; 1982 Nov; 32(5):347-53. PubMed ID: 7161767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model.
    Bedirli A; Gokahmetoglu S; Sakrak O; Ersoz N; Ayangil D; Esin H
    Am J Surg; 2003 Apr; 185(4):339-43. PubMed ID: 12657386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group.
    Dellinger EP; Babineau TJ; Bleicher P; Kaiser AB; Seibert GB; Postier RG; Vogel SB; Norman J; Kaufman D; Galandiuk S; Condon RE
    Arch Surg; 1999 Sep; 134(9):977-83. PubMed ID: 10487593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis.
    Williams DL; Li C; Ha T; Ozment-Skelton T; Kalbfleisch JH; Preiszner J; Brooks L; Breuel K; Schweitzer JB
    J Immunol; 2004 Jan; 172(1):449-56. PubMed ID: 14688354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan).
    de Felippe Júnior J; da Rocha e Silva Júnior M; Maciel FM; Soares Ade M; Mendes NF
    Surg Gynecol Obstet; 1993 Oct; 177(4):383-8. PubMed ID: 8211583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.
    Babineau TJ; Marcello P; Swails W; Kenler A; Bistrian B; Forse RA
    Ann Surg; 1994 Nov; 220(5):601-9. PubMed ID: 7979607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucan-induced enhancement of host resistance in experimental intraabdominal sepsis.
    Lahnborg G; Hedström KG; Nord CE
    Eur Surg Res; 1982; 14(6):401-8. PubMed ID: 7173285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effect of splenectomy in experimental peritonitis.
    Moustoukas N; Browder W; Gleason C; Di Luzio N; Nichols RL
    J Surg Res; 1985 Jun; 38(6):574-81. PubMed ID: 4010267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal antibiotics increase tumor necrosis factor-alpha and cardiac output in rats after cecal ligation and puncture.
    Stockwell JA; Huang YC; Su YF; Piantadosi CA
    Circ Shock; 1994 Feb; 42(2):68-75. PubMed ID: 8013063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model.
    Kaiser AB; Kernodle DS
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2449-51. PubMed ID: 9736583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients.
    Babineau TJ; Hackford A; Kenler A; Bistrian B; Forse RA; Fairchild PG; Heard S; Keroack M; Caushaj P; Benotti P
    Arch Surg; 1994 Nov; 129(11):1204-10. PubMed ID: 7979954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary metastases neutralization and tumor rejection by in vivo administration of beta glucan and bispecific antibody.
    Penna C; Dean PA; Nelson H
    Int J Cancer; 1996 Jan; 65(3):377-82. PubMed ID: 8575861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunopotentiator of beta-1,6;1,3 D-glucan prevents diabetes and insulitis in BB rats.
    Kida K; Inoue T; Kaino Y; Goto Y; Ikeuchi M; Ito T; Matsuda H; Elliott RB
    Diabetes Res Clin Pract; 1992 Aug; 17(2):75-9. PubMed ID: 1425150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bacterial sepsis on gluconeogenic capacity in the rat.
    Holman JM; Saba TM
    J Surg Res; 1988 Aug; 45(2):167-75. PubMed ID: 3043107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
    Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
    J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice.
    Niederman R; Kelderman H; Socransky S; Ostroff G; Genco C; Kent R; Stashenko P
    Arch Oral Biol; 2002 Aug; 47(8):613-8. PubMed ID: 12221019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tuftsin and splenectomy on mortality after intraabdominal sepsis.
    Baker CC; Gaines HO; Niven-Fairchild AT
    J Surg Res; 1984 May; 36(5):499-502. PubMed ID: 6727327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax-protective effects of yeast beta 1,3 glucans.
    Kournikakis B; Mandeville R; Brousseau P; Ostroff G
    MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.